Axonics Inc
NASDAQ:AXNX
| Market Cap (Intraday) | 3.41B |
| Current PE | N/A |
| Forward PE | 167.38 |
| 2yr Forward PE | 88.09 |
| 10-Day MA | $67.45 |
| 50-Day MA | $68.01 |
| 200-Day MA | $60.51 |
Axonics Inc Stock, NASDAQ:AXNX
26 Technology Drive, Irvine, California 92618
United States of America
Phone: +1.949.396.6322
Number of Employees: 797
Description
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.